Abstract
Generally, in out-patient practice an antibiotic is chosen after making a clinical diagnosis and taking into account the most probable causative agents of that particular type of infection. Except in urinary tract infections and some cases of middle ear and throat infections, etiological microbiological tests are rarely done. The dose and duration of antibiotic therapy is decided on empirical bases. Even at hospitals, where more than one-third of the admitted patients obtain antibiotics during the visit (Pestotnik et al. 1990), microbiological diagnosis of the suspected bacterial infection is available in less than half of the cases (Moss et al. 1983). Again, in most instances the treatment is empirical. The dose of antibiotic is determined by crude patient data, such as weight or surface area, age and renal function if the drug is eliminated by kidneys. Excellent handbooks are available for a more individualized prescription of antibiotics (e.g. Norris et al. 1989). These also give the drug concentrations obtained in serum and some other body fluids for the most commonly used doses and ways of administration. Microcomputer-based programs to assist clinical pharmacokinetic consultant services have been developed for aminoglycosides and some other antibiotics (Schentag and Adelman 1983). These may decrease the need for serum concentration measurements of antibiotics (Lumio 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson AC, Hodges GR, Barnes WG (1976) Determination of serum gentamicin sulfate levels: ordering patterns and use as a guide to therapy. Arch Intern Med 136: 785–787
Anderson ET, Young LS, Hewitt WL (1976) Simultaneous antibiotic levels in “breakthrough” gram-negative rod bacteremia. Am J Med 61: 493–497
Arcieri GM, Becker N, Esposito B, Griffith E, Heyd A, Neumann C, O’Brien B, Schacht P (1989) Safety of intravenous ciprofloxacin. Am J Med 87 (Suppl 5A): 925–978
Bergan T, Engeset A, Olszewski W (1987) Does serum protein binding inhibit tissue penetration of antibiotics? Rev Infect Dis 9: 713–718
Black J, Hunt TL, Godley PJ, Matthew E (1987) Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis. J Infect Dis 155: 968–972
Calain P, Waldvogel F (1990) Clinical efficacy of teicoplanin. Eur J Clin Microbiol Infect Dis 9: 127–129
Carbon C, Weber P, Levy M, Boussougant Y, Cerf M (1987) Short-term ciprofloxacin therapy for typhoid fever. J Infect Dis 155: 883–889
Cipolle RJ, Seifert RD, Zaske DE, Strate RG (1980) Systemically individualizing tobramycin dosage regimens. J Clin Pharmacol 20: 570–580
Don Brown R, Campoli-Richards DM (1989) Antimicrobial therapy in neonates, infants and children. Clin Pharmacokinet 17 (Suppl 1): 105–115
Groot R de, Smith AL (1987) Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. Clin Pharmacokinet 13: 228–253
Lietman PS (1989) Pharmacokinetics of antimicrobial agents. In: Mandell GL, Douglas Jr RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 228–230
Lumio J (1987) Tehokas ja turvallinen aminoglykosidihoito — onko ATK:sta apua. Suom Lääkäril 42: 271–277
Manian FA, Stone WJ, Alford RH (1990) Adverse antibiotic effects associated with renal insufficiency 12: 236–249
Meyers BR, Wilkinson P (1989) Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection of dosage. Clin Pharmacokinet 17: 385–395
Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155: 93–99
Moss F, McNicol MW, McSwiggan DA, Miller DL (1983) Survey of antibiotic prescribing in a district general hospital. I. Pattern of use. Lancet II: 349–352
Nix DE, Sands MF, Peloquin CA, Vari AJ, Cumbo TJ, Vance JW, Fracasso JE, Schentag JJ (1987) Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Am J Med 82 (Suppl 4A): 352–256
Noone P, Parsons TMC, Pattison JR, Slack RCB, Garfield-Davis D (1974) Experience in monitoring gentamycin therapy during treatment of serious gram-negative sepsis. Br Med J I: 477–481
Norris S, Nightingale CH, Mandell GL (1989) Tables of antimicrobial agent pharmacology. In: Mandell GL, Douglas Jr RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 434–460
Peltola H, Anttila M, Renkonen O-V and the Finnish Study Group (1989) Randomized comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet L 1281–1287
Pestotnik SL, Evans RS, Burke JP, Gardner RM, Classen DC (1990) Therapeutic antibiotic monitoring: surveillance using a computerized expert system. Am J Med 88: 43–48
Ryan DM, Cars O, Hoffstedt B (1986) The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 18: 381–388
Ryback SA, Lerner DP, Levine LM, Albrecht PL, McNeil GA, Thompson MT, Kenny W (1989) Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Interscience Conf Antimicrobial agents and chemotherapy, Abstr 1343
Schentag JJ (1989) Clinical significance of antibiotic tissue penetration. Clin Pharmacokinet 16: 25–31
Schentag JJ, Adelman MH (1983) A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model. Drug Intell Clin Pharm 17: 528–531
Schentag JJ, Smith IL, Swanson DJ, de Angelis C, Fracasso JE, Vari A, Vance JW (1984) Role for dual individualization with cefmenoxime. Am J Med 77 (Suppl 6A): 43–50
Soe GB, Overturf GD (1987) Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, cefoperazone and other new cephalosporins. Rev Infect Dis 9: 719–736
Tack KJ, Sabath LD (1982) The significance of serum levels of antimicrobial agents. In: Lourian V (ed) Significance of medical microbiology in the case of patients, USA pp 383–393
Wenk W, Vozeh S, Follath F (1984) Serum level monitoring of antibacterial drugs. A review. Clin Pharmacokinet 9: 475–492
Wolfson JS, Swartz MN (1985) Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med 312: 968–975
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lumio, J. (1991). Clinical Needs for Assays of New Antimicrobial Agents. In: Vaheri, A., Tilton, R.C., Balows, A. (eds) Rapid Methods and Automation in Microbiology and Immunology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76603-9_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-76603-9_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76605-3
Online ISBN: 978-3-642-76603-9
eBook Packages: Springer Book Archive